Introduction: Global AI-based Drug Discovery Market, 2020-28
The global AI-based Drug Discovery market report is analyzed based on its market share by value and volume. A regional, country, and global level analysis of all the AI-based Drug Discovery segments is done in the report. The study includes all major geographic regions across the world influencing the AI-based Drug Discovery market. Key insights of the AI-based Drug Discovery market are dominating factors, prospect growth opportunities, restraints, and challenges are given in the report. The finding of the report is supported by porter’s five forces analysis, competitiveness analysis, assessment of key characteristics of the competitive landscape, and raw material analysis. The research methodologies and the resultant data provided in the report match your business needs.
Competition Assessment: Global AI-based Drug Discovery Market
1. 3BIGS, , 2. 3W Partners, , 3. 6 Dimensions Capital, , 4. 8VC, , 5. 99andBeyond, , 6. A2A Pharmaceuticals, , 7. Abalone Bio, , 8. AbbVie, , 9. AbCellera, , 10. Abstract Ventures, , 11. Accelerate Long Island, , 12. Accenture, , 13. Accutar Biotech, , 14. Acellera, , 15. Acequia Capital, , 16. AcuraStem, , 17. Adagene, , 18. ADC Therapeutics, , 19. ADEL , , 20. Advantage Capital, , 21. AdynXX, , 22. Agent Capital, , 23. AGORANO, , 24. AI Therapeutics, , 25. Ai-biopharma, , 26. Aigenpulse, , 27. Air Street Capital, , 28. Ajou University, , 29. Akashi Therapeutics, , 30. Albany Molecular Research, , 31. A-Level Capital, , 32. Alexandria Real Estate Equities, , 33. Alibaba Cloud, , 34. Allergan, , 35. Alliance for Clinical Trials in Oncology, , 36. Alloy Therapeutics, , 37. Almac Diagnostic Services, , 38. Almirall, , 39. Alphanosos, , 40. ALS Association, , 41. ALS Investment Fund, , 42. Altos Ventures, , 43. Amadeus Capital Partners, , 44. Amadeus Capital Partners, , 45. Amazon Web Services, , 46. Amazon Web Services (AWS), , 47. AME Cloud Ventures, , 48. American Society of Clinical Oncology, , 49. Amgen, , 50. Amgen Ventures, , 51. Amidi Group, , 52. Amplify Partners, , 53. Amplitude, , 54. Anagenesis Biotechnologies, , 55. Andreessen Horowitz, , 56. Angel CoFund, , 57. Anima Biotech, , 58. Ansa Biotechnologies, , 59. Antiverse, , 60. ApexQubit, , 61. Aqemia, , 62. Arbutus Biopharma, , 63. ARCH Venture Partners, , 64. ArcTern Ventures, , 65. Arctoris, , 66. Ardigen, , 67. Arpeggio Biosciences, , 68. Artis Ventures, , 69. Arzeda, , 70. Asset Management Ventures, , 71. Astellas Pharma, , 72. Astia Angels, , 73. AstraZeneca, , 74. AstraZeneca’s Centre for Genomics Research, , 75. ATAI Life Sciences , , 76. Atinum Investment, , 77. Atlantic Labs, , 78. Atlas Venture, , 79. Atomico, , 80. Atomwise, , 81. Atrius Health, , 82. AUM Biosciences , , 83. Auransa, , 84. Aurinvest, , 85. Auvergne-Rhône-Alpes regional council, , 86. AVIC Trust, , 87. AxoSim, , 88. B Capital Group, , 89. BABEL Ventures, , 90. Baidu Ventures, , 91. Baillie Gifford, , 92. Balderton Capital, , 93. Bangarang Group, , 94. Battelle Center for Science, Engineering, and Public Policy, Ohio State University, , 95. Bavarian Nordic, , 96. Bayer, , 97. Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC), , 98. Beiersdorf, , 99. Benevolent AI, , 100. BERG, , 101. Better Ventures, , 102. Bezos Expeditions, , 103. Big Data Institute, , 104. BigHat Biosciences, , 105. Bill & Melinda Gates Foundation, , 106. BioAge Labs, , 107. Bioeconomy Capital, , 108. BioFocus DPI, , 109. BioInvent International, , 110. Biomea Healthcare, , 111. BioMotiv, , 112. Bionano Genomics, , 113. BioNTech, , 114. Biorelate, , 115. Bios Partners, , 116. BioSymetrics, , 117. biotx.ai, , 118. BioVentures Investors, , 119. Bioverge, , 120. Biovista, , 121. BioXcel Therapeutics, , 122. BlackRock, , 123. Block.one, , 124. Bloomberg Beta, , 125. Blue Bear Ventures, , 126. bluebird bio, , 127. Boehringer Ingelheim, , 128. Bold Capital Partners, , 129. Bpifrance, , 130. Brace Pharma Capital, , 131. Brain Canada, , 132. Breakout Labs, , 133. BridgeBio Pharma, , 134. Brigham and Women’s Hospital, , 135. Brightspark Ventures, , 136. Bristol-Myers Squibb, , 137. Broad Institute, , 138. btov Partners, , 139. Builders VC, , 140. Bulba Ventures, , 141. Busolantix Investment, , 142. BVF Partners, , 143. C4X Discovery, , 144. Caffeinated Capital, , 145. Calibr, , 146. California Institute of Biomedical Research, , 147. Cambia Health Solutions, , 148. Cambridge Cancer Genomics, , 149. Cambridge Research Centre, , 150. Cancer Genetics , , 151. Cantos Ventures, , 152. CARB-X , , 153. CareDx, , 154. CaroCure, , 155. Casdin Capital, , 156. Catalio Capital Management, , 157. Catapult Ventures, , 158. Cathay Innovation, , 159. Causaly, , 160. CB Lux, , 161. CECS, , 162. Celgene, , 163. Cellarity, , 164. Celsius Therapeutics, , 165. Center for the Advancement of Science in Space, , 166. CENTOGENE, , 167. Centre for the Development of Industrial Technology (CDTI), , 168. Cerebras, , 169. Cerevel Therapeutics, , 170. Charcot–Marie–Tooth Association, , 171. Charles River Laboratories, , 172. ChemAlive, , 173. ChemAxon , , 174. ChemDiv, , 175. ChemPass, , 176. ChemSpace, , 177. Chiesi Farmaceutici, , 178. Children’s Tumor Foundation, , 179. China Canada Angels Alliance, , 180. China International Capital Corporation, , 181. China Life Healthcare Fund, , 182. China Oncology Focus, , 183. Chinese Academy of Medical Sciences, , 184. Cigna Ventures, , 185. City Hill Ventures, , 186. Civilization Ventures, , 187. CJ HealthCare, , 188. Claremont Creek Ventures, , 189. Clarus Ventures, , 190. Cleveland Clinic, , 191. CLI Ventures, , 192. Climate-KIC Accelerator, , 193. Cloud Pharmaceuticals, , 194. CMT Research Foundation , , 195. Collaborations Pharmaceuticals, , 196. Collaborative Drug Discovery, , 197. Collective Scientific , , 198. Colt Ventures, , 199. ConcertAI, , 200. Conifer Point Pharmaceuticals, , 201. Cormorant Asset Management, , 202. Cosine, , 203. Cota Capital, , 204. CPP Investments, , 205. CQDM – Consortium de recherche biopharmaceutique, , 206. Creative Destruction Lab, , 207. Cresset, , 208. CrystalGenomics, , 209. CTI Life Sciences Fund, , 210. Cultivian Sandbox Ventures, , 211. CVC, , 212. CVS Health, , 213. Cyclica, , 214. CytoReason, , 215. Daewoong Pharmaceutical, , 216. Danhua Venture Capital, , 217. Dante Labs, , 218. Data4cure, , 219. Dataspora, , 220. Datavant, , 221. DCVC, , 222. DEARGEN, , 223. Deep Genomics, , 224. Deep Knowledge Ventures, , 225. DeepCure, , 226. DeepMatter, , 227. DeepTrait, , 228. Deerfield Management, , 229. Delin Ventures, , 230. Denali Therapeutics, , 231. Denovicon Therapeutics, , 232. Denovium, , 233. Department of Health and Social Care, , 234. DEXSTR, , 235. Diamond Light Source, , 236. DNAnexus , , 237. DNDi, , 238. Dolby Family Ventures, , 239. Dow AgroSciences, , 240. Drive Capital, , 241. Droia Oncology Ventures, , 242. DSC Investment, , 243. Dualogics, , 244. Dynamk Capital, , 245. Dyno Therapeutics, , 246. Echo Health Ventures, , 247. EcoR1 Capital, , 248. EDBI, , 249. EIC Accelerator, , 250. Eight Roads, , 251. Elad Gil, , 252. Elaia, , 253. Elevian, , 254. Eli Lilly, , 255. Elsevier, , 256. Elucidata, , 257. Embark Ventures, , 258. Empire State Development, , 259. Empirico, , 260. Enamine, , 261. Endogena Therapeutics, , 262. Endure Capital, , 263. Engine Biosciences, , 264. Enterprise Ireland, , 265. Envisagenics, , 266. Epic Capital Management, , 267. Epic Ventures, , 268. Erasca, , 269. e-therapeutics, , 270. Euretos, , 271. European Investment Bank, , 272. European Union, , 273. Eurostars, , 274. Evaxion Biotech, , 275. Evotec, , 276. Ewha Womans University, , 277. Excelra, , 278. Executive Agency for Small and Medium-sized Enterprises (EASME), , 279. Exscientia, , 280. Felicis Ventures, , 281. Fidelity Asia Fund, , 282. Fidelity Biosciences, , 283. Fifty Years, , 284. Financière Boscary, , 285. FinLab, , 286. First Round Capital, , 287. First Star Ventures, , 288. Flagship Pioneering, , 289. Flybridge Capital Partners, , 290. FMC, , 291. Foresite Capital, , 292. Forma Therapeutics, , 293. Formic Ventures, , 294. Foundation for Angelman Syndrome Therapeutics (FAST), , 295. Founders Factory, , 296. Founders Fund, , 297. Fountain Therapeutics, , 298. Fox Chase Cancer Center , , 299. F-Prime Capital, , 300. FREES FUND, , 301. Frontier Medicines, , 302. FundersClub, , 303. Future Ventures, , 304. G3 Therapeutics, , 305. Galapagos, , 306. Gatehouse Bio, , 307. GC Pharma, , 308. Geisinger, , 309. Genedata, , 310. Genentech, , 311. General Atlantic, , 312. General Catalyst, , 313. Genesen, , 314. Genesis Therapeutics, , 315. Genialis, , 316. Genmab, , 317. Genomatica , , 318. Genome Biologics, , 319. Genome Institute of Singapore, , 320. Genomenon, , 321. Genomics England, , 322. Genuity Science, , 323. Gero, , 324. Gi Global Health Fund, , 325. Gilead Sciences, , 326. GlaxoSmithKline, , 327. Global Brain, , 328. Global Founders Capital, , 329. GM&C; Life Sciences Fund, , 330. GNS Healthcare, , 331. Golden Ventures, , 332. Google, , 333. Google Ventures, , 334. Gopher Asset Management, , 335. Gordian Biotechnology, , 336. Government of Canada , , 337. Government of Switzerland, , 338. GP Healthcare Capital, , 339. GPG Ventures, , 340. Grand Challenges Canada, , 341. Green Park & Golf Ventures, , 342. GreenSky Capital, , 343. Gritstone Oncology, , 344. GT Healthcare Capital Partners, , 345. Gustave Roussy, , 346. Hafnium Labs, , 347. Hanhai Studio, , 348. Harbour Antibodies, , 349. Harbour BioMed, , 350. Harris & Harris Group, , 351. HCS, , 352. Health Wildcatters, , 353. HealthInc, , 354. Healx, , 355. Heritage Provider Network, , 356. Hewlett Packard Enterprise (HPE), , 357. Hibiskus Biopharma, , 358. Hike Ventures, , 359. Hinge Therapeutics, , 360. Hiventures Investment Fund, , 361. HOF Capital, , 362. HotSpot Therapeutics, , 363. Huadong Medicine, , 364. Human Capital, , 365. Hyperplane Venture Capital, , 366. IA Ventures, , 367. IBM, , 368. Ichor Biologics, , 369. IDG Capital, , 370. IIT Kharagpur, , 371. Iktos, , 372. IMM Investment, , 373. Immunocure Discovery Solutions, , 374. InfoChem, , 375. InnoPharmaScreen, , 376. Innophore, , 377. Innoplexus, , 378. Innospark Ventures, , 379. Innova31, , 380. Innovate NY Fund, , 381. Innovate UK, , 382. Innovation Endeavors, , 383. Innovation Fund Denmark, , 384. Innovative Medicines Initiative (IMI), , 385. Inovia Capital, , 386. inSili.com, , 387. Insiliance, , 388. Insilico Medicine, , 389. Insitro, , 390. Institut Carnot CALYM, , 391. Institut Gustave Roussy, , 392. Institut Pasteur Korea, , 393. Institute of Cancer Research, London, , 394. Institute of Materia Medica, , 395. Intel, , 396. Intel Capital, , 397. Intellegens, , 398. IntelliCyt, , 399. Intermountain Ventures, , 400. Interprotein, , 401. Intuition Systems, , 402. InveniAI, , 403. InVivo AI, , 404. Invus, , 405. Ionis, , 406. IP Group, , 407. IPF Partners, , 408. IQVIA, , 409. Ireland Strategic Investment Fund, , 410. I-Stem, , 411. IT-Translation, , 412. Janssen Pharmaceutica, , 413. Jiangsu Chia Tai Fenghai Pharmaceutical, , 414. Jiangsu Hansoh Pharmaceutical Group, , 415. JLABS, , 416. Johns Hopkins School of Medicine, , 417. Johns Hopkins University, , 418. Johnson & Johnson, , 419. Johnson & Johnson Innovation – JJDC, , 420. Juvena Therapeutics, , 421. Juvenescence, , 422. JW Pharmaceutical, , 423. K Cube Ventures, , 424. K9 Ventures, , 425. KB Securities, , 426. Kebotix, , 427. Keio University , , 428. KemPharm, , 429. Khosla Ventures, , 430. Kindred Capital, , 431. Kinetic Discovery, , 432. King Star Capital, , 433. King’s College London, , 434. Korea Atomic Energy Research Institute (KAERI), , 435. Korea Development Bank, , 436. Korea Fixed-Income Investment Advisory, , 437. Korea Investment Partners, , 438. Korea Research Institute of Chemical Technology (KRICT), , 439. Ksilink, , 440. KTB Network, , 441. La Financiere Gaspard, , 442. Labcyte, , 443. LabGenius, , 444. LabKey, , 445. Lansdowne Partners, , 446. Lantern Pharma, , 447. LanzaTech, , 448. Laurion Capital Management, , 449. Lawrence Livermore National Laboratory, , 450. Laxai Life Sciences, , 451. LB Investment, , 452. Leaps by Bayer, , 453. LEO Pharma, , 454. Lhasa, , 455. LifeForce Capital , , 456. LifeSci Venture Partners, , 457. Lightspeed Venture Partners, , 458. Lilly Asia Ventures, , 459. Linguamatics, , 460. LMU University Hospital, , 461. Lodo Therapeutics, , 462. Long Island Emerging technologies Fund (LIETF), , 463. Longevity Fund, , 464. Loup Ventures, , 465. Lundbeck, , 466. Lux Capital, , 467. Luxembourg Centre for Systems Biomedicine (LCSB), , 468. M12, , 469. MAbSilico, , 470. Macroceutics, , 471. Magnetic Ventures, , 472. Manchester Tech Trust Angels, , 473. Mannin Research, , 474. Marathon Venture Capital, , 475. MaRS Catalyst Fund, , 476. Maruho, , 477. Massachusetts Life Sciences Center, , 478. MassBiologics, , 479. Maxygen, , 480. MBC BioLabs, , 481. McQuibban Lab, , 482. MDS Foundation, , 483. Medchemica, , 484. Medical Prognosis Institute , , 485. Medirita, , 486. Memorial Sloan Kettering Cancer, , 487. Menlo Ventures, , 488. Menten AI, , 489. Merck, , 490. Merck Accelerator, , 491. Mercury Fund, , 492. Meridian Street Capital, , 493. Micar Innovation, , 494. Michael J. Fox Foundation, , 495. Microsoft, , 496. Microsoft Ventures, , 497. MidCap Financial, , 498. Mila, , 499. Mirae Asset Venture Investment, , 500. MIT delta v, , 501. Mitsui, , 502. Molecule, , 503. Molecule.one, , 504. Moleculomics, , 505. Molomics, , 506. Monsanto Growth Ventures, , 507. MPM Capital, , 508. MRL Ventures Fund, , 509. Mubadala Capital, , 510. Multiple Myeloma Research Foundation , , 511. Muscular Dystrophy Association, , 512. Muscular Dystrophy UK, , 513. myTomorrows, , 514. Nan Fung Life Sciences, , 515. Nanna Therapeutics, , 516. Nashville Biosciences, , 517. National Cancer Institute, , 518. National Center for Advancing Translational Sciences ( NCATS ), , 519. National Center for Research and Development, , 520. National Institute of Neurological Disorders and Stroke (NINDS), , 521. National Institute on Aging (NIA), , 522. National Institutes of Health, , 523. National Institutes of Small Business Technology Transfer, , 524. National Instrumentation Center for Environmental Management, , 525. National Research Council Canada, , 526. National Science Foundation, , 527. National Science Foundation Small Business Innovation Research (NSF SBIR) program, , 528. Nektar Therapeutics, , 529. Nest.Bio Ventures, , 530. Nestlé, , 531. Neuropore Therapies, , 532. NeuroTheryX, , 533. New Protein Capital, , 534. New Wave Ventures, , 535. New World TMT, , 536. New York Medical College, , 537. NewDo Venture, , 538. Nex Cubed, , 539. nference, , 540. NJF Capital, , 541. Nonacus , , 542. Northpond Ventures, , 543. Notable Labs, , 544. Novartis, , 545. Novo Holdings, , 546. Novo Nordisk, , 547. NPIF – Maven Equity Finance, , 548. Numedii, , 549. Nuritas, , 550. NVIDIA, , 551. O2h Ventures, , 552. Oak Ridge National Laboratory, , 553. Obvious Ventures, , 554. OCA Ventures, , 555. OccamzRazor, , 556. Octopus Ventures, , 557. Olaris, , 558. Oncologie, , 559. OncoStatyx, , 560. One Way Ventures, , 561. OneThree Biotech, , 562. Ono Pharmaceutical, , 563. Optibrium, , 564. Optum Venture, , 565. OrbiMed, , 566. OS Fund, , 567. OSE Immunotherapeutics, , 568. OSEO, , 569. Overkill Ventures, , 570. OVP Venture Partners, , 571. OWKIN, , 572. Oxford Drug Design, , 573. Panache Ventures, , 574. PAREXEL, , 575. Parinvest, , 576. Parker Institute for Cancer Immunotherapy, , 577. Parkinson’s UK, , 578. Partner Fund Management, , 579. Pavilion Capital, , 580. PEACCEL, , 581. Pear VC, , 582. PENDING.AI, , 583. Pentech Ventures, , 584. Peptone, , 585. Peptris Technologies, , 586. PercayAI, , 587. Perceptive Advisors, , 588. Pfizer, , 589. Pfizer Venture Investments, , 590. Pharmacelera, , 591. Pharmavite, , 592. PharmCADD, , 593. PharmEnable, , 594. Pharnext, , 595. Pharos iBio, , 596. Phenomic AI, , 597. PhoreMost, , 598. Pi Campus, , 599. PIKAS d.o.o., , 600. Plex Research, , 601. Plug and Play Ventures, , 602. Polaris Partners, , 603. Polaris Quantum Biotech, , 604. Polyclone Bioservices, , 605. Porton, , 606. PostEra, , 607. PrecisionLife, , 608. Predictive Oncology, , 609. Prefix Capital, , 610. Presight Capital, , 611. Primary Venture Partners, , 612. Prime Movers Lab, , 613. Primordial Genetics, , 614. Prism Pharma, , 615. Promega, , 616. Propagator Ventures, , 617. ProteinQure, , 618. ProteiQ Biosciences, , 619. QIAGEN, , 620. Qiming Venture Partners, , 621. Quantitative Medicine, , 622. Qulab, , 623. RA Capital Management, , 624. Radical Ventures, , 625. Rahko, , 626. Ramen Ventures, , 627. RaQualia Pharma, , 628. Real Ventures, , 629. RealHealthData, , 630. Recursion Pharmaceuticals, , 631. Redalpine, , 632. Redbiotec, , 633. Redmile Group, , 634. Redpoint Ventures, , 635. Refactor Capital, , 636. Regeneron Pharmaceuticals, , 637. Regional Cancer Centre (RCC), , 638. Relation Therapeutics, , 639. Relay Therapeutics, , 640. Remedium AI, , 641. RenalytixAI, , 642. Reneo Capital, , 643. Renren, , 644. ReproCell, , 645. Repurpose.AI, , 646. Research Triangle Park, , 647. Resonant Therapeutics, , 648. Reverie Labs, , 649. ReviveMed, , 650. Rigetti Computing, , 651. Rising Tide, , 652. Rivas Capital, , 653. Roche, , 654. Romulus Capital, , 655. Rough Draft Ventures, , 656. RT Partners, , 657. Samsara BioCapital, , 658. Sanabil Investments, , 659. Sanofi, , 660. Sanofi , , 661. Santen Pharmaceutical, , 662. Saphetor, , 663. Sapio Sciences, , 664. Sapir Venture Partners, , 665. Sarepta Therapeutics, , 666. SARomics Biostructures, , 667. Saverna Therapeutics, , 668. Schrödinger, , 669. SciFi VC, , 670. Scripps Research, , 671. Sea Lane Ventures, , 672. Searchbolt, , 673. Selvita, , 674. Sema4, , 675. SEngine Precision Medicine, , 676. Seoul National University, , 677. Sequoia Capital, , 678. Sequoia China, , 679. Seraph Group, , 680. Serra Ventures, , 681. Servier, , 682. Siemens, , 683. SIG, , 684. Sinequa, , 685. Sinopia Biosciences, , 686. Sinovation Ventures, , 687. Sirenas, , 688. SK Biopharmaceuticals , , 689. SK Holdings, , 690. Smilegate Investment, , 691. Sofinnova Partners, , 692. SoftBank Ventures, , 693. SoftTech VC, , 694. Solasta Ventures, , 695. SolveBio, , 696. SOM Biotech, , 697. Soma Capital, , 698. SOSV, , 699. SparkBeyond, , 700. Spektron Systems, , 701. Spring Discovery, , 702. Square 1 Bank, , 703. SR One, , 704. SRI International, , 705. Stage Ventu,
Available Sample Report in PDF Version along with Graphs and [email protected] https://www.orbisresearch.com/contacts/request-sample/5843424?utm_source=PoojaA3
The investment research data offered in the report allows the stakeholders and investors in the AI-based Drug Discovery market to focus on the ongoing and upcoming investment opportunities and makes them aware of the investment scenarios across the AI-based Drug Discovery market. The strategic intelligence capabilities boost your business extension and help better understand the potential of diverse industries in the AI-based Drug Discovery market. Qualitative and quantitative analysis of AI-based Drug Discovery market scenarios as per the geographical regions and performance of its different regions is provided in the report. The research analysis study is customized according to the business requirements of the market participants. Furthermore, the report highlights specifications and challenges, including multiple methodologies to extract accurate data figures and facts, detailed interviews, and studies the competitive landscape of the AI-based Drug Discovery market
Segmentation by Type:
drug discovery steps (target identification, target validation, hit identification, lead identification and lead optimization),
Based on application, segmentation is primarily been harnessed to understand the scope of application based on industrial demands and user preferences.
Segmentation by Application:
end users (pharmaceutical / biotechnology companies, and academic institutes).
Regional Segmentation identifies Americas, European nations, APAC countries and MEA as popular growth hubs.
Get ToC for the overview of the premium report @ https://www.orbisresearch.com/reports/index/ai-based-drug-discovery-market-global-analysis-2021-2028-insights-on-leading-players-type-applications-regions-and-future-opportunities?utm_source=PoojaA3
The report highlights various aspects in the AI-based Drug Discovery market and answers relevant questions on the AI-based Drug Discovery market:
1. What are the best investment options to launch new products and offer advanced services in the AI-based Drug Discovery market?
2. What are the value propositions relevant to the customer or market segment a business should focus on while making new research or investing funds in the AI-based Drug Discovery market?
3. What policy changes will help stakeholders to boost their supply chain and demand network?
4. Which regions would demand more products and services offered in certain segments in the forecast period?
5. What are the strategies that have helped the established players to reduce supplier costs, procurement and, logistics costs?
6.C-suite perspective leveraged to move businesses to new growth trajectory?
7. What are the government interventions boosting the AI-based Drug Discovery market or government regulations that may challenge the status of the regional and global industries in the AI-based Drug Discovery market?
8. How will the political and economic crisis affect opportunities in AI-based Drug Discovery growth areas?
Make an Enquiry for purchasing this Report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/5843424?utm_source=PoojaA3
Table of Contents
Chapter One: Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by AI-based Drug Discovery Revenue
1.4 Market Analysis by Type
1.4.1 Global AI-based Drug Discovery Market Size Growth Rate by Type: 2020 VS 2028
1.5 Market by Application
1.5.1 Global AI-based Drug Discovery Market Share by Application: 2020 VS 2028
1.6 Study Objectives
1.7 Years Considered
Chapter Two: Global Growth Trends by Regions
2.1 AI-based Drug Discovery Market Perspective (2015-2025)
2.2 AI-based Drug Discovery Growth Trends by Regions
2.2.1 AI-based Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2028
2.2.2 AI-based Drug Discovery Historic Market Share by Regions (2015-2020)
2.2.3 AI-based Drug Discovery Forecasted Market Size by Regions (2021-2028)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 AI-based Drug Discovery Market Growth Strategy
2.3.6 Primary Interviews with Key AI-based Drug Discovery Players (Opinion Leaders)
Chapter Three: Competition Landscape by Key Players
3.1 Global Top AI-based Drug Discovery Players by Market Size
3.1.1 Global Top AI-based Drug Discovery Players by Revenue (2015-2020)
3.1.2 Global AI-based Drug Discovery Revenue Market Share by Players (2015-2020)
3.1.3 Global AI-based Drug Discovery Market Share by Company Type (Tier 1, Tier Chapter Two: and Tier 3)
3.2 Global AI-based Drug Discovery Market Concentration Ratio
3.2.1 Global AI-based Drug Discovery Market Concentration Ratio (CRChapter Five: and HHI)
3.2.2 Global Top Chapter Ten: and Top 5 Companies by AI-based Drug Discovery Revenue in 2020
3.3 AI-based Drug Discovery Key Players Head office and Area Served
3.4 Key Players AI-based Drug Discovery Product Solution and Service
3.5 Date of Enter into AI-based Drug Discovery Market
3.6 Mergers & Acquisitions, Expansion Plans
About Us :
With unfailing market gauging skills, has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem solving intent, ever willing to mold boundaries to scale heights in market interpretation.
Contact Us :
Hector Costello
Senior Manager Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas 75204, U.S.A.
Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155